← Every applicant

Steranco Hlthcare FDA Approvals

3 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product
LACOSAMIDENew drugMay 21, 2026SOLUTION, ORAL
OXCARBAZEPINENew drugMar 9, 2026SUSPENSION, ORAL
NYSTATINNew drugFeb 5, 2026SUSPENSION, ORAL

Related datasets